Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?

Haemostasis

Volumn 30, Issue SUPPL. 2, 2000, Pages 136-140

  Bossuyt, Patrick P M M ^a,b   Prins, Martin M H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ambulatory care; Clinical trials; Costs and cost analysis; Economic evaluation studies; Low molecular weight heparin; Treatment of venous thromboembolism

Indexed keywords

HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DEEP VEIN THROMBOSIS; HOSPITAL CARE; HUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0034462184     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054180     Document Type: Conference Paper

References (10)

1. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
2. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
3. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
4. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis - An economic evaluation
5. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis
6. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection
7. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis
8. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis
9. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects
10. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin